Uncategorised - European Medical Journal

Physician assessing an older patient’s breathing during a COPD consultation.

ATS 2026: Itepekimab COPD Trial Shows Mixed Results

Itepekimab reduced COPD exacerbations in one Phase III trial, but the effect was not replicated across AERIFY-2.

chlorinated water

Tap Water Chlorination Linked to Infant Gut Changes

Chlorinated drinking water exposure in infancy was associated with increased antimicrobial resistance pathways in the gut microbiome in a new trial.

Abolition NHS England

Government to Abolish NHS England in Major Health Service Overhaul

NHS Modernisation Bill announced abolishing NHS England and reshaping NHS governance alongside wider health reforms.

Preschool child receiving respiratory treatment for acute wheezing symptoms

Azithromycin Shows No Benefit for Preschool Wheezing

Azithromycin did not improve acute preschool wheezing symptoms compared with placebo in an emergency department trial.

Extreme heat ICU capacity gaps across vulnerable U.S. states

Heat Vulnerability Outpaces ICU Capacity in U.S.

Extreme heat is exposing state-level ICU capacity gaps in regions already facing high climate-related health risk.

19 May 2026

IL-33 Is Not Just IL-33: There Is More Than One Side to the COPD Story

COPD exacerbations place a considerable burden on patients and healthcare systems.1-3 Even with optimised maintenance therapy, many…

Dermatologist examining inflamed skin during chronic prurigo assessment.

Chronic Prurigo Care Needs Standardized Guidance

Chronic prurigo recommendations clarify diagnosis, severity assessment, and personalized treatment pathways for patients with persistent itch.

Patient holding foot in discomfort, representing gout flare resolution and recovery from joint pain

Patients Describe What Gout Flare Resolution Means

Gout flare resolution means more than pain relief, with patients describing recovery as a return to normal daily life.

Microscope used in respiratory infection research for Mycobacterium avium complex lung disease

ATS 2026: Phase IIIb Trial Advances MAC Lung Disease Care

A Phase IIIb trial is evaluating inhaled amikacin for newly diagnosed Mycobacterium avium complex lung disease.

Ebola virus

Ebola outbreak renews focus on broad-spectrum antivirals

Rising Bundibugyo Ebola cases in DRC and Uganda have highlighted treatment gaps.